Home Newsfeeds Goldman Sachs Downgrades STMicroelectronics to Sell

Goldman Sachs Downgrades STMicroelectronics to Sell

Goldman Sachs analyst Alexander Duval downgrades STMicroelectronics (NYSE:STM) from Neutral to Sell.

byBenzinga Newsdesk

January 11, 2023

1 minute read

Goldman Sachs analyst Alexander Duval downgrades STMicroelectronics (NYSE:STM) from Neutral to Sell.

News

BitNile Metaverse Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Happy Mohamed

June 1, 8:40 AM

BitNile Metaverse, Inc. (NASDAQ:BNMV) ("BitNile" or the "Company") the company operating the rapidly growing virtual world, BitNile.com (the "Platform"), today announced that it

BNMV

Analyst Ratings

13 Analysts Have This to Say About Atlassian

By Benzinga Insights

August 30, 3:00 PM

Analysts have provided the following ratings for Atlassian (NASDAQ:TEAM) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

TEAM

Tesla Reports Downbeat Results, Joins Hexcel, Columbia Banking System And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Avi Kapoor

January 25, 6:52 AM

U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 80 points on Thursday.

CCCS

CNBX Acquires A Controlling Interest In Cancer Immunotherapy Developer

By Vuk Zdinjak

November 8, 11:18 AM

CNBX Pharmaceuticals Inc. (OTCQB: CNBX) has acquired a controlling interest in TaGeza Biopharmaceuticals Ltd. The TaGeza research team remains committed to the company, and co-founder professor Benjamin Dekel (MD, PhD) will continue to serve as the company's chief scient

CNBX

Goldman Sachs Downgrades STMicroelectronics to Sell

Related Posts

BitNile Metaverse Regains Compliance With Nasdaq Minimum Bid Price Requirement

13 Analysts Have This to Say About Atlassian

Tesla Reports Downbeat Results, Joins Hexcel, Columbia Banking System And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

CNBX Acquires A Controlling Interest In Cancer Immunotherapy Developer